![[up]](/style/images/multi_up.png)
Up a levelArticle
Majewski, Matthäus 
ORCID: 0000-0002-3731-2441, Paffenholz, Pia ORCID: 0000-0002-8209-7795, Ruf, Christian, Che, Yue, Seidel, Christoph, Heinzelbecker, Julia ORCID: 0000-0001-8993-7171, Schmelz, Hans‐Ulrich, Matthies, Cord, Albers, Peter, Bokemeyer, Carsten, Heidenreich, Axel ORCID: 0000-0002-2511-3664, Pichler, Martin ORCID: 0000-0002-8701-9462 and Nestler, Tim ORCID: 0000-0001-6033-6364
(2023).
Misuse of tumor marker levels leads to an insufficient International Germ Cell Consensus Classification (IGCCCG) risk group assignment and impaired treatment.
Cancer Medicine, 12 (16).
pp. 16829-16836.
Wiley.
ISSN 2045-7634
Paffenholz, Pia ORCID: 0000-0002-8209-7795, Seelemeyer, F. ORCID: 0000-0001-8411-8353, Gößmann, Ruben, von Brandenstein, Melanie ORCID: 0000-0002-1499-7644, Pfister, David ORCID: 0000-0002-2109-3221 and Heidenreich, Axel ORCID: 0000-0002-2511-3664
(2025).
Very Early Relapse (< 1 year) in de novo Metastatic Seminoma is Associated With Reduced Overall Survival.
Clinical Genitourinary Cancer, 23 (4).
pp. 1-7.
Elsevier.
ISSN 15587673
Steenbock, Olivia ORCID: 0009-0002-7208-8104, Paffenholz, Pia ORCID: 0000-0002-8209-7795, Rieger, Constantin ORCID: 0009-0000-3993-7974, Heidenreich, Julian ORCID: 0009-0001-7556-7445, Pfister, David ORCID: 0000-0002-2109-3221, von Brandenstein, Melanie ORCID: 0000-0002-1499-7644 and Heidenreich, Axel ORCID: 0000-0002-2511-3664
(2025).
NGS-basierte („next generation sequencing“) molekulare Panelanalyse des metastasierten Prostatakarzinoms: Wie häufig finden wir therapierbare Mutationen?
Die Urologie, 64 (3).
pp. 256-268.
Springer Nature.
ISSN 2731-7064